The Law Offices of Frank R. Cruz continues its investigation of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

IF YOU ARE AN INVESTOR WHO LOST MONEY ON PETMED EXPRESS, INC. (PETS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.

What Is The Investigation About?

On June 10, 2025, PetMed disclosed that it would be delaying the release of its fourth quarter and fiscal year 2025 financial results because it “requires additional time to complete the year-end audit process."

On this news, PetMed’s stock price fell $0.47, or 11.2%, to close at $3.72 per share on June 11, 2025, thereby injuring investors.

Then, on July 1, 2025, PetMed announced that it had initiated an internal investigation due to a whistleblower complaint regarding the timing of revenue recognition and certain autoship orders during the fourth quarter of 2025.

Then, on August 11, 2025, PetMed disclosed that it would be unable to timely file its fourth quarter and full fiscal year 2025 financial results, citing its ongoing internal investigation. The following day, the Company announced the immediate resignations of its CEO and CFO.

Then, on October 7, 2025, PetMed disclosed that its Audit Committee had concluded that financial statements from fiscal years 2023 and 2024 “should no longer be relied upon, as a result of . . . income statement classification errors[.]”

Contact Us To Participate or Learn More:

If you purchased PetMed securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:

The Law Offices of Frank R. Cruz,

2121 Avenue of the Stars, Suite 800,

Century City, California 90067

Call us at: 310-914-5007

Email us at: info@frankcruzlaw.com

Visit our website at: www.frankcruzlaw.com.

Follow us for updates on Twitter at twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251010930813/en/